TAP Consulting’s CVS Health CVS Stock Holding History

TAP Consulting’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-528	Closed	-$54K	–	231
2021 Q4	$54K	Buy	+528	New	+$48.8K	0.01%	245

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TAP Consulting's CVS Position: Q1 2022 in Review

TAP Consulting sold out of CVS Health (CVS) in Q1 2022, closing a stake of 528 shares — an estimated $54K sold.

TAP Consulting first reported a position in CVS in Q4 2021 and held it in 1 quarter. The position peaked at $54K in Q4 2021. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

TAP Consulting reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
TAP Consulting sold 528 CVS Health shares in Q1 2022, an estimated $54K.
TAP Consulting first reported a position in CVS Health in Q4 2021 and held it in 1 quarter.
TAP Consulting's CVS Health position peaked at $54K in Q4 2021.
2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on TAP Consulting's 13F filing for Q1 2022, filed 26 Apr 2022.